Efficacy and Safety of the Aflibercept Biosimilar SB15 in Neovascular Age-Related Macular Degeneration

Efficacy, durability, and safety of intravitreal faricimab up to every 16 weeks for neovascular age-related macular degeneration (TENAYA and LUCERNE): two randomised, double-masked, phase 3, non-inferiority trials

(2022) Jeffrey S Heier et al.   LANCET

Retinal vein occlusion (RVO) guideline: executive summary

(2022) Luke Nicholson et al.   EYE

Efficacy and Safety of Biosimilar FYB201 Compared With Ranibizumab in Neovascular Age-Related Macular Degeneration

(2021) Frank G. Holz et al.   OPHTHALMOLOGY

Efficacy and Safety of a Proposed Ranibizumab Biosimilar Product vs a Reference Ranibizumab Product for Patients With Neovascular Age-Related Macular Degeneration

(2020) Se Joon Woo et al.   JAMA Ophthalmology

HAWK and HARRIER: Phase 3, Multicenter, Randomized, Double-Masked Trials of Brolucizumab for Neovascular Age-Related Macular Degeneration

(2019) Pravin U. Dugel et al.   OPHTHALMOLOGY

Diagnosis and treatment guideline for myopic choroidal neovascularization due to pathologic myopia

(2018) Kyoko Ohno-Matsui et al.   PROGRESS IN RETINAL AND EYE RESEARCH

Statement of the BVA, the DOG, and the RG on treatment of choroidal neovascularization in diseases other than neovascular age-related macular degeneration

(2018) et al.   OPHTHALMOLOGE

Guidelines for the Management of Diabetic Macular Edema by the European Society of Retina Specialists (EURETINA)

(2017) Ursula Schmidt-Erfurth et al.   OPHTHALMOLOGICA

Unknown

(2016)   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Intravitreal Aflibercept (VEGF Trap-Eye) in Wet Age-related Macular Degeneration

(2012) Jeffrey S. Heier et al.   OPHTHALMOLOGY

VEGF and Age-related Macular Degeneration

(2009) Gareth J. McKay et al.   OPHTHALMOLOGY

Randomized, Double-Masked, Sham-Controlled Trial of Ranibizumab for Neovascular Age-related Macular Degeneration: PIER Study Year 1

(2008) Carl D. Regillo et al.   AMERICAN JOURNAL OF OPHTHALMOLOGY

Ranibizumab versus Verteporfin Photodynamic Therapy for Neovascular Age-Related Macular Degeneration: Two-Year Results of the ANCHOR Study

(2008) David M. Brown et al.   OPHTHALMOLOGY